According to the UNODC (United Nations Office on Drugs and Crime) the production and distribution of fraudulent medical products is a problem that is ever-present throughout today’s global markets.
Currently pharmaceutical companies use varied anti-counterfeiting technologies (embedded barcodes, holograms, fluorescent inks,) to ensure the uninterrupted distribution of their (authentic) products from manufacturer to pharmacist to costumer. This allows pharmacists to identify suspicious medications as possible counterfeits before passing them onto the final customer, the patient.
However, these safeguards have two main drawbacks, a) they can require specialised equipment to read, and b) the rise in the popularity of online purchasing completely circumvents these checks.
INOOCQ is a CEA start-up that hopes to provide a practical and accessible solution to these problems. Taking advantage of the prevalence of smart phones, we provide camera readable speciality inks to mark and identify products. The properties of these speciality inks allows them to be identified by our built for purpose identification app.
INOOCQ combines advanced materials (“augmented inks”) and informatics (“the app”) to produce a product that is universally accessible to the general population. Potential clients (industrial and people) can combine INOOCQ’s technology with their own pre-existing track and trace codes, i.e. datamatrix or QR codes, to enhance the security of their products, while their customers can easily identify the veracity of their purchase with the push of a button.
Contacts:
✦ Bruno LAGUITTON bruno.laguitton@cea.fr ✉
✦ Michéal MOLONEY micheal.moloney@cea.fr ✉